- Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma
[作者:Yang, HI; Yeh, SH; Chen, PJ; Iloeje, UH; Jen, CL; Su, J; Wang, LY; Lu, SN; You, SL; Chen, DS; Liaw, YF; Chen, CJ,期刊:Journal of the National Cancer Institute, 页码:1134-1143 , 文章类型: Article,,卷期:2008年100-16]
- Background The risk of hepatocellular carcinoma (HCC) increases with increasing level of hepatitis B virus (HBV) in serum (viral load). However, it is unclear whether genetic characteristics of HBV, including HBV genotyp...
- Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian Prostate Cancer Group-4 randomized trial
[作者:Bill-Axelson, A; Holmberg, L; Filen, F; Ruutu, M; Garmo, H; Busch, C; Nordling, S; Haggman, M; Andersson, SO; Bratell, S; Spangberg, A; Palmgren, J; Adami, HO; Johansson, JE,期刊:Journal of the National Cancer Institute, 页码:1144-1154 , 文章类型: Article,,卷期:2008年100-16]
- Background The benefit of radical prostatectomy in patients with early prostate cancer has been assessed in only one randomized trial. In 2005, we reported that radical prostatectomy improved prostate cancer survival com...
- Antitumor effects of doxorubicin followed by zoledronic acid in a mouse model of breast cancer
[作者:Ottewell, PD; Monkkonen, H; Jones, M; Lefley, DV; Coleman, RE; Holen, I,期刊:Journal of the National Cancer Institute, 页码:1167-1178 , 文章类型: Article,,卷期:2008年100-16]
- Background The potent antiresorptive drug zoledronic acid (Zol) enhances the antitumor effects of chemotherapy agents in vitro. We investigated the effects of clinically achievable doses of doxorubicin (Dox) and Zol, giv...
- Residual risk of breast cancer recurrence 5 years after adjuvant therapy
[作者:Brewster, AM; Hortobagyi, GN; Broglio, KR; Kau, SW; Santa-Maria, CA; Arun, B; Buzdar, AU; Booser, DJ; Valero, V; Bondy, M; Esteva, FJ,期刊:Journal of the National Cancer Institute, 页码:1179-1183 , 文章类型: Article,,卷期:2008年100-16]
- There is limited prognostic information to identify breast cancer patients who are at risk for late recurrences after adjuvant or neoadjuvant systemic therapy (AST). We evaluated the residual risk of recurrence and progn...
- Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age
[作者:Brown, LM; Devesa, SS; Chow, WH,期刊:Journal of the National Cancer Institute, 页码:1184-1187 , 文章类型: Article,,卷期:2008年100-16]
- Rapid increases in the incidence of adenocarcinoma of the esophagus have been reported among white men. We further explored the temporal patterns of this disease among white individuals by sex, stage, and age by use of d...
- A systematic review and meta-analysis of the pharmacological treatment of cancer-related fatigue
[作者:Minton, O; Richardson, A; Sharpe, M; Hotopf, M; Stone, P,期刊:Journal of the National Cancer Institute, 页码:1155-1166 , 文章类型: Review,,卷期:2008年100-16]
- Background Cancer-related fatigue is an important clinical problem. It is common, distressing, and often difficult to treat. There is a role for drug treatment of cancer-related fatigue, but no consensus has been reached...
|